Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Development of SCOPE: Social and Clinical Opioid Use Disorder Predisposition Evaluation.

Created on 05 Aug 2026

Authors

Soraya Mehdipour, Carla Marienfeld, Gregory Polston, Rodney A Gabriel

Published in

Journal of addiction medicine. Aug 05, 2026. Epub Aug 05, 2026.

Abstract

Our study aimed to identify social determinants of health (SDoH), demographic, and clinical features associated with opioid use disorder (OUD) and then to develop a risk calculator, termed Social and Clinical Opioid Use Disorder Predisposition Evaluation (SCOPE), that clinicians may use at the bedside to risk-stratify for OUD.
Participant data from the All of Us Research Program were used. Multivariable logistic regression was used to identify various SDoH, demographic, and clinical predictors for OUD. The dependent variable of OUD was defined as occurring ≥90 days after participants completed a survey that queried questions related to SDoH. Calculated odds ratios from the model were used to construct a score-based calculator, SCOPE, and model performance was measured by area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity.
There were 624,431 included participants, of whom 2475 (0.39%) had OUD that was diagnosed >90 days after survey completion. SCOPE's performance was assessed using 10-fold cross-validation, resulting in an average AUROC [SD] of 0.85 [0.011], specificity of 78% [0.16%], and sensitivity of 78% [2.42%]. Defining a cutoff score of 8 as high-risk yielded a sensitivity of 0.79 [95% CI: 0.76-0.83], specificity of 0.76 [95% CI: 0.75-0.76], positive likelihood ratio of 3.35, and negative likelihood ratio of 0.26.
We identified individual- and SDoH-related risk factors for OUD and developed SCOPE, which may be used as a clinical decision-making aid for personalized risk identification of OUD.

PMID:
42554165
Bibliographic data and abstract were imported from PubMed on 05 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement